Loading...

Apogee Therapeutics, Inc.

APGE•NASDAQ
Healthcare
Biotechnology
$85.61
$-2.68(-3.04%)
U.S. Market opens in 49h 27m

Apogee Therapeutics, Inc. (APGE) Stock Overview

Explore Apogee Therapeutics, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap4.8B
P/E Ratio-20.28
EPS (TTM)$-4.22
ROE-0.37%
Fundamental Analysis

AI Price Forecasts

1 Month$73.65
3 Months$76.72
1 Year Target$78.55

APGE Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Apogee Therapeutics, Inc. (APGE) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 53.87, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $78.55.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -20.28 and a market capitalization of 4.8B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-3.04%
5-Day Change
-7.20%
1-Month Change
17.27%
3-Month Change
22.27%
6-Month Change
60.56%
Year-to-Date (YTD) Change
13.42%
1-Year Change
131.07%
3-Year Change
303.25%
5-Year Change
303.25%
All-Time (Max) Change
303.25%

Contact Information

https://www.apogeetherapeutics.com
650-394-5230
221 Crescent Street, Waltham, MA, 02453

Company Facts

196 Employees
IPO DateJul 14, 2023
CountryUS
Actively Trading

Frequently Asked Questions